Oncologists are increasingly favoring CAR T-cell therapy’s early-line use in relapsed/refractory multiple myeloma despite challenges like cost and access.
University of Pittsburgh School of Medicine and UPMC scientist-surgeons announced today in Cell Reports Medicine that giving ...
Canopy, the first Continuous Care Platform for oncology, today announced a multi-year partnership with Texas Oncology, one of the nation's largest community-based oncology practices, encompassing ...
Scientists create biodegradable, structurally colored glitter from cellulose nanocrystals, eliminating microplastic waste.
Setting new standards in design and range: the new fully electric Audi A6 e-tron launches in Ireland
The all-new, fully electric Audi A6 e-tron has arrived in Ireland. The Audi A6 e-tron is the first fully electric Audi model ...
The uptick in measles cases has left many people wondering about early signs of measles, whether they need an updated vaccine and treatment options.
BACKGROUND: Despite the high morbidity and mortality of heart failure with preserved ejection fraction (HFpEF), treatment ...
Immune Amnesia: How the Texas Measles Outbreak Could Promote the Spread of Other Infectious Diseases
The measles virus attacks long-lived immune cells, reducing antibody-mediated protection from other infectious diseases and ...
Amplified spontaneous emission is a physical phenomenon that entails the amplification of the light spontaneously emitted by ...
Plasma cell leukemia (PCL) is a rare disease that may present de novoor secondary to plasma cell myeloma. Advanced disease and extramedullary involvement are common clinical features at presentation.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback